A Democratic lawmaker is raising new concerns about a Food and Drug Administration program designed to drastically shorten ...
The U.S. Food and Drug Administration (FDA) has approved a drug to control seizures in dogs with idiopathic epilepsy, a type ...
FDA drug alerts in endocrinology, including drug approvals, drug warnings, FDA medical device recalls, and FDA drug label ...
By Ahmed Aboulenein WASHINGTON, Feb 1 (Reuters) - The U.S. Food and Drug Administration on Sunday began accepting requests to ...
The West Virginia House of Delegates and Mississippi House of Representatives have both approved bills to support research in ...
Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, ...
The FDA issued a recall Wednesday for a honey energy supplement after an undeclared erectile dysfunction medication was found ...
Representative Jake Auchincloss of Massachusetts took issue with the agency’s handling of the program and questioned its legal underpinnings, noting that Congress did not sign off on the plan.
The FDA approved Darzalex Faspro with Velcade, Revlimid and dexamethasone for newly diagnosed multiple myeloma ineligible for ...
A milestone in the treatment of Duchenne muscular dystrophy (DMD) passed recently with remarkably little public notice. That ...
The FDA commissioner's effort to shorten the review of drugs favored by the Trump administration is causing alarm across the agency, stoking worries that the plan may run afoul of legal, ethical and ...
The FDA approved re-administration of iDose TR for patients with healthy corneas, enhancing treatment flexibility for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results